- Supported exchanges /
- SHE /
- 002826.SHE
Tibet Aim Pharm Inc (002826 SHE) stock market data APIs
Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; and NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain, as well as coma, spinal cord injury, cerebral infarction, hemorrhage, etc. It also provides Carbetocin injections for prevention of postpartum hemorrhage; Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.
Tibet Aim Pharm Inc Financial Data Overview
| 11.05 | |
| 11.17 | |
| - | |
| 11.47 | |
| 10.95 | |
| 5.551-13.2348 | |
| 2 107 M | |
| 65 | |
| 191 M | |
| 642 M | |
| 0.0118 | |
| 0.0027 | |
| 0.339 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Tibet Aim Pharm Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 642 M
- EBITDA 76 900 K
- Earnings Per Share 0.17
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Tibet Aim Pharm Inc Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Tibet Aim Pharm Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
